Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Eplerenone,"Hypertension, treatment refractory, intolerant to spironolactone",Eplerenone (Inspra),Options for investment,Community and Hospital,Cardiovascular System
